nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP2C8—Levothyroxine—hypothyroidism	0.181	0.506	CbGbCtD
Secobarbital—CYP2C8—Liotrix—hypothyroidism	0.176	0.494	CbGbCtD
Secobarbital—CHRFAM7A—corpus luteum—hypothyroidism	0.059	0.182	CbGeAlD
Secobarbital—CHRNA7—corpus luteum—hypothyroidism	0.0476	0.147	CbGeAlD
Secobarbital—GRIK2—cerebellar cortex—hypothyroidism	0.036	0.111	CbGeAlD
Secobarbital—CHRNA4—cochlea—hypothyroidism	0.0264	0.0813	CbGeAlD
Secobarbital—GRIK2—nerve—hypothyroidism	0.0132	0.0407	CbGeAlD
Secobarbital—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.0124	0.0509	CcSEcCtD
Secobarbital—Hyperkinesia—Levothyroxine—hypothyroidism	0.0124	0.0509	CcSEcCtD
Secobarbital—CHRNA4—nerve—hypothyroidism	0.0106	0.0327	CbGeAlD
Secobarbital—Hypotension—Liothyronine—hypothyroidism	0.00964	0.0396	CcSEcCtD
Secobarbital—Hyperkinesia—Liotrix—hypothyroidism	0.00911	0.0374	CcSEcCtD
Secobarbital—CYP1A2—urine—hypothyroidism	0.00818	0.0252	CbGeAlD
Secobarbital—Body temperature increased—Liothyronine—hypothyroidism	0.00815	0.0335	CcSEcCtD
Secobarbital—CYP2C9—urine—hypothyroidism	0.00776	0.0239	CbGeAlD
Secobarbital—Tension—Dextrothyroxine—hypothyroidism	0.00609	0.025	CcSEcCtD
Secobarbital—Tension—Levothyroxine—hypothyroidism	0.00609	0.025	CcSEcCtD
Secobarbital—Nervousness—Dextrothyroxine—hypothyroidism	0.00603	0.0248	CcSEcCtD
Secobarbital—Nervousness—Levothyroxine—hypothyroidism	0.00603	0.0248	CcSEcCtD
Secobarbital—Agitation—Levothyroxine—hypothyroidism	0.0057	0.0234	CcSEcCtD
Secobarbital—Agitation—Dextrothyroxine—hypothyroidism	0.0057	0.0234	CcSEcCtD
Secobarbital—Angioedema—Levothyroxine—hypothyroidism	0.00567	0.0233	CcSEcCtD
Secobarbital—Angioedema—Dextrothyroxine—hypothyroidism	0.00567	0.0233	CcSEcCtD
Secobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00556	0.0743	CbGpPWpGaD
Secobarbital—Anxiety—Levothyroxine—hypothyroidism	0.00527	0.0216	CcSEcCtD
Secobarbital—Anxiety—Dextrothyroxine—hypothyroidism	0.00527	0.0216	CcSEcCtD
Secobarbital—Confusional state—Levothyroxine—hypothyroidism	0.00511	0.021	CcSEcCtD
Secobarbital—Confusional state—Dextrothyroxine—hypothyroidism	0.00511	0.021	CcSEcCtD
Secobarbital—Shock—Levothyroxine—hypothyroidism	0.00498	0.0205	CcSEcCtD
Secobarbital—Shock—Dextrothyroxine—hypothyroidism	0.00498	0.0205	CcSEcCtD
Secobarbital—GRIK2—heart—hypothyroidism	0.0049	0.0151	CbGeAlD
Secobarbital—GABRA4—heart—hypothyroidism	0.00461	0.0142	CbGeAlD
Secobarbital—Tension—Liotrix—hypothyroidism	0.00448	0.0184	CcSEcCtD
Secobarbital—Nervousness—Liotrix—hypothyroidism	0.00443	0.0182	CcSEcCtD
Secobarbital—Agitation—Liotrix—hypothyroidism	0.0042	0.0172	CcSEcCtD
Secobarbital—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00417	0.0171	CcSEcCtD
Secobarbital—Feeling abnormal—Levothyroxine—hypothyroidism	0.00417	0.0171	CcSEcCtD
Secobarbital—Angioedema—Liotrix—hypothyroidism	0.00417	0.0171	CcSEcCtD
Secobarbital—Syncope—Liotrix—hypothyroidism	0.00409	0.0168	CcSEcCtD
Secobarbital—Loss of consciousness—Liotrix—hypothyroidism	0.00401	0.0165	CcSEcCtD
Secobarbital—Body temperature increased—Dextrothyroxine—hypothyroidism	0.004	0.0164	CcSEcCtD
Secobarbital—Body temperature increased—Levothyroxine—hypothyroidism	0.004	0.0164	CcSEcCtD
Secobarbital—CHRNA7—heart—hypothyroidism	0.00399	0.0123	CbGeAlD
Secobarbital—Anxiety—Liotrix—hypothyroidism	0.00387	0.0159	CcSEcCtD
Secobarbital—GABRA4—pituitary gland—hypothyroidism	0.00385	0.0119	CbGeAlD
Secobarbital—CHRNA7—cardiovascular system—hypothyroidism	0.00377	0.0116	CbGeAlD
Secobarbital—Confusional state—Liotrix—hypothyroidism	0.00376	0.0154	CcSEcCtD
Secobarbital—CHRNA4—cardiovascular system—hypothyroidism	0.00372	0.0115	CbGeAlD
Secobarbital—CHRFAM7A—blood—hypothyroidism	0.00369	0.0114	CbGeAlD
Secobarbital—Shock—Liotrix—hypothyroidism	0.00367	0.0151	CcSEcCtD
Secobarbital—CHRFAM7A—thyroid gland—hypothyroidism	0.00356	0.011	CbGeAlD
Secobarbital—Hypotension—Liotrix—hypothyroidism	0.00348	0.0143	CcSEcCtD
Secobarbital—CHRFAM7A—female gonad—hypothyroidism	0.00344	0.0106	CbGeAlD
Secobarbital—GABRA3—thyroid gland—hypothyroidism	0.00341	0.0105	CbGeAlD
Secobarbital—GRIA2—testis—hypothyroidism	0.00335	0.0103	CbGeAlD
Secobarbital—GABRG2—pituitary gland—hypothyroidism	0.00322	0.00993	CbGeAlD
Secobarbital—Vomiting—Levothyroxine—hypothyroidism	0.00322	0.0132	CcSEcCtD
Secobarbital—Vomiting—Dextrothyroxine—hypothyroidism	0.00322	0.0132	CcSEcCtD
Secobarbital—Rash—Dextrothyroxine—hypothyroidism	0.00319	0.0131	CcSEcCtD
Secobarbital—Rash—Levothyroxine—hypothyroidism	0.00319	0.0131	CcSEcCtD
Secobarbital—Dermatitis—Levothyroxine—hypothyroidism	0.00319	0.0131	CcSEcCtD
Secobarbital—Dermatitis—Dextrothyroxine—hypothyroidism	0.00319	0.0131	CcSEcCtD
Secobarbital—Constipation—Liotrix—hypothyroidism	0.00319	0.0131	CcSEcCtD
Secobarbital—Headache—Levothyroxine—hypothyroidism	0.00317	0.013	CcSEcCtD
Secobarbital—Headache—Dextrothyroxine—hypothyroidism	0.00317	0.013	CcSEcCtD
Secobarbital—GABRA5—testis—hypothyroidism	0.00314	0.00967	CbGeAlD
Secobarbital—GRIA2—cerebellum—hypothyroidism	0.00309	0.00953	CbGeAlD
Secobarbital—Feeling abnormal—Liotrix—hypothyroidism	0.00307	0.0126	CcSEcCtD
Secobarbital—CHRFAM7A—testis—hypothyroidism	0.00305	0.0094	CbGeAlD
Secobarbital—Nausea—Dextrothyroxine—hypothyroidism	0.00301	0.0124	CcSEcCtD
Secobarbital—Nausea—Levothyroxine—hypothyroidism	0.00301	0.0124	CcSEcCtD
Secobarbital—GABRA6—cerebellum—hypothyroidism	0.00299	0.00921	CbGeAlD
Secobarbital—CHRNA7—adrenal gland—hypothyroidism	0.00298	0.00918	CbGeAlD
Secobarbital—CHRNA7—blood—hypothyroidism	0.00298	0.00918	CbGeAlD
Secobarbital—Body temperature increased—Liotrix—hypothyroidism	0.00295	0.0121	CcSEcCtD
Secobarbital—CHRNA4—adrenal gland—hypothyroidism	0.00294	0.00906	CbGeAlD
Secobarbital—GABRA3—testis—hypothyroidism	0.00292	0.009	CbGeAlD
Secobarbital—CHRNA7—thyroid gland—hypothyroidism	0.00288	0.00886	CbGeAlD
Secobarbital—GRIK2—cerebellum—hypothyroidism	0.00279	0.00861	CbGeAlD
Secobarbital—CHRNA7—female gonad—hypothyroidism	0.00278	0.00856	CbGeAlD
Secobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00275	0.0367	CbGpPWpGaD
Secobarbital—Hypersensitivity—Liotrix—hypothyroidism	0.00275	0.0113	CcSEcCtD
Secobarbital—GABRA2—adrenal gland—hypothyroidism	0.00263	0.00811	CbGeAlD
Secobarbital—GABRA4—cerebellum—hypothyroidism	0.00263	0.0081	CbGeAlD
Secobarbital—Dizziness—Liotrix—hypothyroidism	0.00246	0.0101	CcSEcCtD
Secobarbital—CHRNA7—testis—hypothyroidism	0.00246	0.00759	CbGeAlD
Secobarbital—GABRB2—testis—hypothyroidism	0.00238	0.00734	CbGeAlD
Secobarbital—Vomiting—Liotrix—hypothyroidism	0.00237	0.00973	CcSEcCtD
Secobarbital—Rash—Liotrix—hypothyroidism	0.00235	0.00965	CcSEcCtD
Secobarbital—Dermatitis—Liotrix—hypothyroidism	0.00235	0.00964	CcSEcCtD
Secobarbital—Headache—Liotrix—hypothyroidism	0.00233	0.00959	CcSEcCtD
Secobarbital—CHRNA4—cerebellum—hypothyroidism	0.00225	0.00692	CbGeAlD
Secobarbital—Nausea—Liotrix—hypothyroidism	0.00221	0.00909	CcSEcCtD
Secobarbital—GABRB2—cerebellum—hypothyroidism	0.0022	0.00678	CbGeAlD
Secobarbital—GABRG2—cerebellum—hypothyroidism	0.0022	0.00678	CbGeAlD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00214	0.0286	CbGpPWpGaD
Secobarbital—GABRA2—cerebellum—hypothyroidism	0.00201	0.00619	CbGeAlD
Secobarbital—CYP2C9—heart—hypothyroidism	0.00199	0.00613	CbGeAlD
Secobarbital—GABRA1—cerebellum—hypothyroidism	0.00194	0.00598	CbGeAlD
Secobarbital—CYP2C9—cardiovascular system—hypothyroidism	0.00188	0.00578	CbGeAlD
Secobarbital—CYP2C8—pituitary gland—hypothyroidism	0.00187	0.00577	CbGeAlD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00174	0.0233	CbGpPWpGaD
Secobarbital—CYP2C8—blood—hypothyroidism	0.00167	0.00515	CbGeAlD
Secobarbital—GRIK2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00157	0.021	CbGpPWpGaD
Secobarbital—CYP1A2—blood—hypothyroidism	0.00156	0.00482	CbGeAlD
Secobarbital—CYP1A2—thyroid gland—hypothyroidism	0.00151	0.00465	CbGeAlD
Secobarbital—CYP2C9—blood—hypothyroidism	0.00148	0.00457	CbGeAlD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00143	0.0191	CbGpPWpGaD
Secobarbital—CYP2C8—testis—hypothyroidism	0.00138	0.00426	CbGeAlD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00138	0.0184	CbGpPWpGaD
Secobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00135	0.018	CbGpPWpGaD
Secobarbital—CYP2C8—liver—hypothyroidism	0.00131	0.00403	CbGeAlD
Secobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00122	0.0164	CbGpPWpGaD
Secobarbital—CYP1A2—liver—hypothyroidism	0.00122	0.00377	CbGeAlD
Secobarbital—GRIK2—Neuronal System—SLC5A7—hypothyroidism	0.0012	0.0161	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0012	0.016	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00116	0.0156	CbGpPWpGaD
Secobarbital—CYP2C9—liver—hypothyroidism	0.00116	0.00358	CbGeAlD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00112	0.015	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—SLC5A7—hypothyroidism	0.00109	0.0146	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00108	0.0144	CbGpPWpGaD
Secobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00103	0.0138	CbGpPWpGaD
Secobarbital—GRIK2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00101	0.0135	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000999	0.0133	CbGpPWpGaD
Secobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000998	0.0133	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000986	0.0132	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000921	0.0123	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—SLC5A7—hypothyroidism	0.00092	0.0123	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000902	0.012	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—SLC5A7—hypothyroidism	0.000892	0.0119	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000876	0.0117	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00086	0.0115	CbGpPWpGaD
Secobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000856	0.0114	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000846	0.0113	CbGpPWpGaD
Secobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000845	0.0113	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000825	0.011	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—NEFL—hypothyroidism	0.000775	0.0104	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000774	0.0103	CbGpPWpGaD
Secobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000773	0.0103	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.000765	0.0102	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.000756	0.0101	CbGpPWpGaD
Secobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000751	0.01	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000751	0.01	CbGpPWpGaD
Secobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000738	0.00985	CbGpPWpGaD
Secobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000725	0.00968	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000721	0.00963	CbGpPWpGaD
Secobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000707	0.00945	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—NEFL—hypothyroidism	0.000705	0.00942	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000695	0.00929	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000691	0.00923	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.000671	0.00897	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.000659	0.00881	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000648	0.00866	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000644	0.0086	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000636	0.00849	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000632	0.00844	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000618	0.00826	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—NEFL—hypothyroidism	0.000593	0.00792	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000581	0.00776	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—NEFL—hypothyroidism	0.000575	0.00768	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000565	0.00754	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000554	0.00741	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000553	0.00738	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000549	0.00733	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000545	0.00728	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000532	0.0071	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—VAV3—hypothyroidism	0.00051	0.00682	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—NEFL—hypothyroidism	0.000493	0.00659	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000487	0.0065	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000465	0.00621	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000447	0.00597	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000445	0.00595	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000433	0.00578	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000425	0.00568	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000418	0.00558	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000411	0.0055	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000407	0.00544	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000406	0.00543	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000372	0.00496	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000361	0.00482	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000356	0.00476	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000354	0.00474	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000348	0.00465	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000341	0.00455	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00034	0.00454	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000337	0.0045	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000308	0.00411	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000299	0.004	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000297	0.00397	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000294	0.00392	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000289	0.00386	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000282	0.00376	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000277	0.0037	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000246	0.00329	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000227	0.00304	CbGpPWpGaD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000185	0.00247	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000184	0.00246	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000164	0.0022	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000162	0.00217	CbGpPWpGaD
Secobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000158	0.00211	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00015	0.002	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000149	0.00198	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000144	0.00193	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000142	0.00189	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000139	0.00186	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000136	0.00181	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000129	0.00173	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000128	0.00171	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000128	0.00171	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000119	0.00159	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000117	0.00156	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—IYD—hypothyroidism	0.000116	0.00154	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000114	0.00152	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000112	0.00149	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00011	0.00146	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000107	0.00143	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ATP5O—hypothyroidism	9.83e-05	0.00131	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—POMC—hypothyroidism	9.8e-05	0.00131	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—IYD—hypothyroidism	9.41e-05	0.00126	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	9.35e-05	0.00125	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TPO—hypothyroidism	9.24e-05	0.00123	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.56e-05	0.00114	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—IYD—hypothyroidism	8.04e-05	0.00107	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ATP5O—hypothyroidism	8e-05	0.00107	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—POMC—hypothyroidism	7.97e-05	0.00106	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TPO—hypothyroidism	7.52e-05	0.001	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.97e-05	0.000931	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ATP5O—hypothyroidism	6.83e-05	0.000913	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—POMC—hypothyroidism	6.81e-05	0.00091	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TPO—hypothyroidism	6.43e-05	0.000858	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.95e-05	0.000795	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TSHB—hypothyroidism	4.28e-05	0.000571	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	3.81e-05	0.000509	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.76e-05	0.000502	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TSHB—hypothyroidism	3.48e-05	0.000465	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC5A5—hypothyroidism	3.2e-05	0.000428	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	3.1e-05	0.000414	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.06e-05	0.000409	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TSHB—hypothyroidism	2.97e-05	0.000397	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.65e-05	0.000354	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.62e-05	0.000349	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC5A5—hypothyroidism	2.61e-05	0.000348	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.23e-05	0.000297	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—POMC—hypothyroidism	1.68e-05	0.000224	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—POMC—hypothyroidism	1.36e-05	0.000182	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—POMC—hypothyroidism	1.17e-05	0.000156	CbGpPWpGaD
